More On

White & Case’s Farrington jumps into pharma M&A groundswell with Hepalink deal

Eases transition of newly formed company

White & Case Partner Rebecca H. Farrington

As the pharmaceutical industry has been on an M&A binge lately, White & Case Partner Rebecca H. Farrington has been taking part, working on the team that advised China-based Shenzhen Hepalink Pharmaceutical Co. Ltd, and its U.S. subsidiary Hepalink USA Inc. on the $337.5 million acquisition of Scientific Protein Laboratories, LLC.

The transaction closed on April 9, after the parties obtained the necessary antitrust and regulatory approvals and clearances in the People's Republic of China, the United States and France, according to White & Case.

Contributing Author

author image

Amy I. Stickel

Amy I. Stickel has extensive experience covering the legal, financial and pharmaceutical industries as a writer and editor. A past managing editor of Corporate Legal Times and...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.